Abstract
Nanomaterials have potential as drug delivery vectors that can improve the chemical stability and pharmacokinetic profile of small molecule drugs or improve drug uptake into solid tumours. However, one consequence of the use of nanosized drug delivery vectors is their potential recognition by tissue macrophages and accumulation in organs of the reticuloendothelial system (RES). While in some instances the uptake of drug loaded nanomaterials or ‘nanomedicines’ into organs of the RES is favoured, in most instances uptake into the RES can limit systemic exposure of the nanomedicine and limit therapeutic utility. Hence, this section discusses ways in which the RES uptake of nanomedicines can either be promoted or inhibited. Specifically, the effect of various physicochemical properties and presence or absence of key RES ‘recognition ligands’ on RES uptake are examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- RES:
-
Reticuloendothelial system
- PAMAM:
-
Polyamidoamine
- PEG:
-
Polyethylene glycol
- DPPC:
-
Dipalmitoyl phosphatidylglycerol
- Succinate:
-
Succinic acid
- Ph-sulphonate:
-
Benzene sulphonate
- Ph-disulphonate:
-
Benzene disulphonate
- TIM:
-
T cell Ig domain and mucin domain
- NPC:
-
Non-parenchymal cell
- HPI:
-
Hydrogenated phosphatidylinositol
- DPPG:
-
1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol)
- DAB:
-
Diaminobutane
- Gd-DAB:
-
Gadolinium conjugated diaminobutane dendrimer
- HLA-DR:
-
Human leukocyte antigen DR
- BAI:
-
Brain specific angiogenesis inhibitor
- GM1:
-
Monosialoganglioside GM1
- DPPC:
-
1,2-dipalmitoyl-sn-glycero-3-phosphocholine
- DSPC:
-
L-alpha-phosphatidylcholine distearoyl
- DSPG:
-
L-alpha-phosphatidyl-DL-glycerol-distearoyl
References
A. Agarwal, H. Kandpal, H.P. Gupta, N.B. Singh, C.M. Gupta, Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice, Antimicrobial Agents and Chemotherapy, 38 (1994) 588–593.
H.B. Agashe, A.K. Babbar, S. Jain, R.K. Sharma, A.K. Mishra, A. Asthana, M. Garg, T. Dutta, N.K. Jain, Investigations on biodiostribution of technetium-99 m-labelled carbohydrate-coated poly (propylene imine) dendrimers, Nanomedicine: Nanotechnology, Biology and Medicine, 3 (2007) 120–127.
W.T. Al Jamal, K.T. Al Jamal, A. Cakebread, J.M. Halket, K. Kostarelos, Blood circulation and tissue biodistribution of lipid-quantum dot (L-QD) hybrid vesicles intravenously administered in mice, Bioconjugate Chemistry, 20 (2009) 1696–1702.
T.M. Allen, G.A. Austin, A. Chonn, L. Lin, K.C. Lee, Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size, Biochimica et Biophysica Acta, 1061 (1991a) 56–64.
T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half lives in vivo, Biochimica et Biophysica Acta, 1066 (1991b) 29–36.
B.J. Boyd, L.M. Kaminskas, P. Karellas, G. Krippner, R. Lessene, C.J.H. Porter, Cationic poly-L-lysine dendrimers: Pharmacokinetics, biodistribution and evidence for metabolism and bioresorption after intravenous administration in rats., Molecular Pharmaceutics, 3 (2006) 614–627.
I. Dufresne, A. Desormeaux, J. Bestman-Smith, P. Gourde, M.J. Tremblay, M.G. Bergeron, Targeting lymph nodes with liposome bearing anti-HLA-DR-Fab’ fragments, Biochimica et Biophysica Acta, 1421 (1999) 284–294.
T. Dutta, M. Garg, N.K. Jain, targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro, European Journal of Pharmaceutical Sciences, 34 (2008) 181–189.
A. Egorova, A. Kiselev, M. Hakli, M. Ruponen, V. Baranov, A. Urtti, Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells, Journal of Gene Medicine, 11 (2009) 772–781.
A.A. Gabizon, Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes, Cancer Research, 52 (1992) 891–896.
A. Gabizon, D. Papahadjopoulos, Liposome frmulations with prolonged circulation time in blood and enhanced uptake by tumors, Proceedings of the National Academy of Science USA, 85 (1988) 6949–6953.
A. Gabizon, D. Papahadjopoulos, The role of surface charge and hydrophilic groups on liposome clearance in vivo, Biochimica et Biophysica Acta, 1103 (1992) 94–100.
A. Gabizon, R. Shiota, D. Papahadjopoulos, Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times, Journal of the National Cancer Institute, 81 (1989) 1484–1488.
A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, D. Papahadjopoulos, Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies, Cancer Research, 50 (1990) 6371–6378.
J.M. Irache, H.H. Salman, C. Gamazo, S. Espuelas, Mannose-targeted systems for the delivery of therapeutics, Expert Opinion in Drug Delivery, 5 (2008) 703–724.
S.K. Jain, Y. Gupta, A. Jain, A.R. Saxena, P. Khare, A. Jain, Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery, Nanomedicine, 4 (2008) 41–48.
L.M. Kaminskas, B.J. Boyd, P. Karellas, S.A. Henderson, M.P. Giannis, G. Krippner, C.J. Porter, Impact of surface derivatisation of poly-L-lysine dendrimers with anionic arylsulphonate or succinate groups on intravenous pharmacokinetics and disposition, Molecular Pharmaceutics, 4 (2007) 949–961.
L.M. Kaminskas, B.J. Boyd, P. Karellas, G.Y. Krippner, R. Lessene, B. Kelly, C.J.H. Porter, The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly-L-lysine dendrimers, Molecular Pharmaceutics, 5 (2008) 449–463.
L.M. Kaminskas, B. Kelly, V. McLeod, B.J. Boyd, G.Y. Krippner, E.D. Williams, C.J.H. Porter, Pharmacokinetics and tumour disposition of PEGylated methotrexate conjugated poly-L-lysine dendrimers, Molecular Pharmaceutics, 6 (2009a) 1190–1204.
L.M. Kaminskas, J. Kota, V.M. McLeod, B.D. Kelly, P. Karellas, C.J.H. Porter, PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats, Journal of Controlled Release, 140 (2009b) 108–116.
C.D. Kaur, M.H. Nahar, N.K. Jain, Lymphatic targeting of zidovudine using surface-engineered liposomes, Journal of Drug Targeting, 16 (2008) 798–805.
S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, M. Hashida, Biodistribution characteristics of mannosylated, fucosylated and galactosylated liposomes in mice, Biochimica et Biophysica Acta, 1524 (2000) 258–265.
S.S. Kim, C. Ye, P. Kumar, I. Chiu, S. Subramanya, P. Shankar, N. Manjunath, Targeted delivery of siRNA to macrophages for anti-inflammatory treatment, Molecular Therapeutics, 18 (2010) 993–1001.
H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, J. Konishi, K. Togashi, M.W. Brechbiel, Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents, Journal of Magnetic Resonance Imaging, 14 (2001a) 705–713.
H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, A. Hiraga, T. Ishimori, Y. Akita, M.H. Mamede, J. Konishi, K. Togashi, Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core, Magnetic Resonance in Medicine, 46 (2001b) 795–802.
H. Kobayashi, S. Kawamoto, P.L. Choyke, N. Sato, M.V. Knopp, R.A. Star, T.A. Waldmann, Y. Tagaya, M.W. Brechbiel, Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography, Magnetic Resonance in Medicine, 50 (2003) 758–766.
H. Kobayashi, S. Kawamoto, M. Bernardo, M.W. Brechbiel, M.V. Knopp, P.L. Choyke, Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging, Journal of Controlled Release, 111 (2006) 343–351.
D.C. Litzinger, A.M. Buiting, N. Van Rooijen, L. Huang, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochimica et Biophysica Acta, 1190 (1994) 99–107.
F. Liu, D. Liu, Serum independent liposome uptake by mouse liver, Biochimica et Biophysica Acta, 1278 (1996) 5–11.
D. Liu, F. Liu, Y.K. Song, Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin, Biochimica et Biophysica Acta, 1235 (1995a) 140–146.
D. Liu, F. Liu, Y.K. Song, Monosialoganglioside GM1 shortens the blood circulation of liposomes in rats, Pharmaceutical Research, 12 (1995b) 508–512.
S.M. Moghimi, Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers, Biochimica et Biophysica Acta, 1590 (2002) 131–139.
K. Morikawa, R. Nayar, I.J. Fidler, In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-phenylalanine (FMLP) incorporated in liposomes, Cancer Immunology and Immunotherapy, 27 (1988) 1–6.
R. Mounzer, P. Shakarin, X. Papademetris, T. Constable, N.H. Ruddle, T.M. Fahmy, Dynamic imaging of lymphatic vessles and lymph nodes using a bimodal nanoparticulate contrast agent, Lymphatic Research and Biology, 5 (2007) 151–158.
A. Nag, P.C. Ghosh, Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver, Journal of Drug Targeting, 6 (1999) 427–438.
N. Nimje, A. Agarwal, G.K. Saraogi, N. Lariya, G. Rai, H. Agarwal, G.P. Agarwal, Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting, Journal of Drug Targeting, 17 (2009) 777–787.
N. Oku, Y. Namba, S. Okada, Tumor accumulation of novel RES-avoiding liposomes, Biochimica et Biophysica Acta, 1126 (1992) 255–260.
C. Oussoren, G. Storm, Lymphatic uptake and biodistributions of liposomes after subcutaneous injection: III. influence of surface modification with poly(ethyleneglycol), Pharmaceutical Research, 14 (1997) 1479–1484.
C. Oussoren, G. Storm, Liposomes to target the lymphatics by subcutaneous administration, Advanced Drug Delivery Reviews, 50 (2001) 143–156.
P.C. Rensen, J.C. Gras, E.K. Lindfors, K.W. van Dijk, J.W. Jukema, T.J. van Berkel, E.A. Biessen, Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class A, Current Drug Discovery Technologies, 3 (2006) 135–144.
H.H. Spanjer, M. van Galen, F.H. Roerdink, J. Regts, G.L. Scherphof, Intrahepatic distribution of small unilamellar liposomes as a function of liposome lipid composition, Biochimica et Biophysica Acta, 863 (1986) 224–230.
L. Thiele, J.E. Deiederichs, R. Reszka, H.P. Merkle, E. Walter, Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells, Biomaterials, 24 (2003) 1409–1418.
S.P. Vyas, Y.K. Katare, V. Mishra, V. Sihorkar, Ligand directed macrophage targeting of amphotericin B loaded liposomes, International Journal of Pharmaceutics, 210 (2000) 1–14.
L. Wan, X. Zhang, S. Pooyan, M.S. Palombo, M.J. Leibowitz, S. Stein, P.J. Sinko, Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages, Bioconjugate Chemistry, 19 (2008) 28–38.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Kaminskas, L.M., Boyd, B.J. (2011). Nanosized Drug Delivery Vectors and the Reticuloendothelial System. In: Prokop, A. (eds) Intracellular Delivery. Fundamental Biomedical Technologies, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1248-5_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-1248-5_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-1247-8
Online ISBN: 978-94-007-1248-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)